4.6 Article

Melatonin receptor 1B gene rs10830963 polymorphism, depressive symptoms and glycaemic traits

Journal

ANNALS OF MEDICINE
Volume 50, Issue 8, Pages 704-712

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/07853890.2018.1509118

Keywords

Depression; diabetes; glycaemic traits; insulin sensitivity and resistance; melatonin; MTNR1B; psychological aspects

Funding

  1. Academy of Finland
  2. ERC Advanced Scientist Grant
  3. Sigrid Juselius Foundation
  4. Doctoral Programme of Psychology, Learning and Communication (University of Helsinki)
  5. Folkhalsan Research Foundation
  6. Nordic Center of Excellence in Disease Genetics, EU (EXGENESIS, EUFP7-MOSAIC)
  7. Signe and Ane Gyllenberg Foundation
  8. Swedish Cultural Foundation in Finland
  9. Finnish Diabetes Research Foundation
  10. Foundation for Life and Health in Finland
  11. Finnish Medical Society
  12. Paavo Nurmi Foundation
  13. Helsinki University Central Hospital Research Foundation
  14. Perklen Foundation
  15. Ollqvist Foundation
  16. Narpes Health Care Foundation
  17. Ahokas Foundation
  18. Ministry of Education in Finland
  19. Municipal Heath Care Center and Hospital in Jakobstad and Health Care Centers in Vaasa, Narpes and Korsholm

Ask authors/readers for more resources

Background: The association between depression and type 2 diabetes is bidirectional. Underlying biological determinants remain elusive. We examined whether a common melatonin receptor 1B gene diabetes risk variant rs10830963 influenced the associations between depressive symptoms and glycaemic traits. Materials: The Prevalence, Prediction and Prevention of Diabetes-Botnia Study participants (n = 4,455) with no diabetes who underwent an oral glucose tolerance test were genotyped for rs10830963 and completed the Mental Health Inventory on depressive symptoms. Results: The rs10830963 did not influence significantly the associations between depressive symptoms and glycaemic traits. Yet, the addition of each copy of the minor G allele of the rs1080963 and higher depressive symptoms were both, independent of each other, associated significantly with higher glucose response (glucose area under the curve), higher insulin resistance (Insulin Sensitivity Index) and lower insulin secretion (Disposition Index). Depressive symptoms, but not rs1080963, were also significantly associated with higher fasting insulin, insulin area under the curve and insulin resistance (Homeostasis Model Assessment, Homeostasis Model Assessment-2); rs1080963, but not depressive symptoms, was significantly associated with higher fasting glucose and lower Corrected Insulin Response. Conclusions: Our study shows that the diabetes risk variant rs10830963 does not contribute to the known comorbidity between depression and type 2 diabetes. Key messages The association between depression and type 2 diabetes is bidirectional. We tested whether a common variant rs10830963 in the gene encoding Melatonin Receptor 1B influences the known association between depressive symptoms and glycaemic traits in a population-based sample from Western Finland. The MTNR1B genetic diabetes risk variant rs10830963 does not contribute to the known comorbidity between depression and type 2 diabetes. Depressive symptoms and rs10830963 are associated with a worse glycaemic profile independently of each other.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available